Rating History for Faeth Therapeutics (FTH) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Brad Canino | New Coverage | Buy (N/A) |
70.00 (N/A) |
39.09 (28.00) |
-28.37% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/15/2026 | Brad Canino | New Coverage | Buy (N/A) |
70.00 (N/A) |
39.09 (28.00) |
-28.37% | Details |